Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 7Stomach Neoplasms 2Rectal Neoplasms 1Pancreatic Neoplasms 1Neutropenia 1Neoplasm Metastasis 1Gastric and Gastroesophageal Junction Adenocarcinoma 1Esophageal Squamous Cell Carcinoma 1EFS 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Anal Cancer Metastatic 1Advanced Solid Tumors 1Advanced Colorectal Cancer 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

pembrolizumab 2Pemetrexed 2Docetaxel 2Carboplatin 2Bevacizumab 2trifluridine tipiracil drug combination 1trametinib 1spartalizumab 1sotorasib 1sintilimab 1palbociclib 1netrin-1 inhibitor NP137 1atezolizumab 1Panitumumab 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Irinotecan 1Injections 1Fluorouracil 1Everolimus 1Drug Therapy 1Cetuximab 1Afatinib 1ASP1570 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Advanced Solid Tumors × trifluridine tipiracil drug combination × Clear all
NCT05083481 2026-05-05

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

Astellas Pharma Inc

Phase 1/2 Active not recruiting
226 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡